Hepatic Disorders and COVID-19: From Pathophysiology to Treatment Strategy
Following the SARS-CoV-2 outbreak and the subsequent development of the COVID-19 pandemic, organs such as the lungs, kidneys, liver, heart, and brain have been identified as priority organs. Liver diseases are considered a risk factor for high mortality from the COVID-19 pandemic. Besides, liver dam...
Main Authors: | Parisa Shiri Aghbash, Hamed Ebrahimzadeh Leylabadlo, Hamidreza Fathi, Mohaddeseh Bahmani, Rojin Chegini, Hossein Bannazadeh Baghi |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2022-01-01
|
Series: | Canadian Journal of Gastroenterology and Hepatology |
Online Access: | http://dx.doi.org/10.1155/2022/4291758 |
Similar Items
-
Monoclonal antibodies in cervical malignancy-related HPV
by: Parisa Shiri Aghbash, et al.
Published: (2022-10-01) -
Rabies Elimination by 2030: What Challenges Does Iran Face?
by: Hamed EBRAHIMZADEH LEYLABADLO, et al.
Published: (2020-06-01) -
Dynamic alterations in white blood cell counts and SARS-CoV-2 shedding in saliva: an infection predictor parameter
by: Parisa Shiri Aghbash, et al.
Published: (2023-06-01) -
Amendment of International Funding Resource Approaches Required to Control HIV
by: Mojtaba MEHTARPOUR, et al.
Published: (2020-04-01) -
siRNA-E6 sensitizes HPV-16-related cervical cancer through Oxaliplatin: an in vitro study on anti-cancer combination therapy
by: Parisa Shiri Aghbash, et al.
Published: (2023-01-01)